CL2014002506A1 - Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido. - Google Patents
Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido.Info
- Publication number
- CL2014002506A1 CL2014002506A1 CL2014002506A CL2014002506A CL2014002506A1 CL 2014002506 A1 CL2014002506 A1 CL 2014002506A1 CL 2014002506 A CL2014002506 A CL 2014002506A CL 2014002506 A CL2014002506 A CL 2014002506A CL 2014002506 A1 CL2014002506 A1 CL 2014002506A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- tablet
- produce
- disacarids
- oligosaccharides
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 3
- 230000000975 bioactive effect Effects 0.000 title 1
- 239000002775 capsule Substances 0.000 title 1
- 150000001720 carbohydrates Chemical class 0.000 title 1
- 150000004676 glycans Chemical class 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 title 1
- 150000002482 oligosaccharides Chemical class 0.000 title 1
- 239000008188 pellet Substances 0.000 title 1
- 229920001282 polysaccharide Polymers 0.000 title 1
- 239000005017 polysaccharide Substances 0.000 title 1
- 239000000843 powder Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
- A23P30/30—Puffing or expanding
- A23P30/32—Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261614994P | 2012-03-23 | 2012-03-23 | |
| US201261642094P | 2012-05-03 | 2012-05-03 | |
| US201261646337P | 2012-05-13 | 2012-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014002506A1 true CL2014002506A1 (es) | 2015-01-09 |
Family
ID=49223367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014002506A CL2014002506A1 (es) | 2012-03-23 | 2014-09-23 | Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2827905B1 (enExample) |
| JP (1) | JP6229188B2 (enExample) |
| KR (1) | KR102062645B1 (enExample) |
| CN (2) | CN114601849A (enExample) |
| AR (1) | AR093204A1 (enExample) |
| AU (1) | AU2013234931B2 (enExample) |
| BR (1) | BR112014023234B1 (enExample) |
| CA (1) | CA2866889C (enExample) |
| CL (1) | CL2014002506A1 (enExample) |
| ES (1) | ES3016483T3 (enExample) |
| IN (1) | IN2014DN08599A (enExample) |
| MX (1) | MX356072B (enExample) |
| MY (1) | MY178686A (enExample) |
| NZ (1) | NZ628912A (enExample) |
| PH (1) | PH12014502092B1 (enExample) |
| RU (1) | RU2666601C2 (enExample) |
| SG (1) | SG11201405478VA (enExample) |
| WO (1) | WO2013142792A1 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140255583A1 (en) * | 2013-03-06 | 2014-09-11 | Sunny Delight Beverages Company | Protein suspension as a beverage opacifier system |
| MX376352B (es) | 2013-10-25 | 2025-03-07 | Nch Corp | Sistema de suministro y composicion probiotica para animales y plantas. |
| US10766799B2 (en) | 2014-05-23 | 2020-09-08 | Nch Corporation | Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method |
| KR102567744B1 (ko) * | 2015-02-11 | 2023-08-18 | 에바 뉴트리션 인크 | 생존 가능한 대장균을 삽입하기 위한 향상된 건조 기질, 이의 제조 방법 및 용도 |
| CA2994112C (en) * | 2015-07-29 | 2023-08-08 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
| AU2016365214B2 (en) * | 2015-12-04 | 2021-02-25 | Advanced Bionutrition Corp. | Stable dry compositions having no or little sugars |
| US11224238B2 (en) * | 2015-12-18 | 2022-01-18 | Société des Produits Nestlé S.A. | Hydration for animals |
| FR3045384B1 (fr) * | 2015-12-18 | 2020-02-07 | Institut National De La Recherche Agronomique | Composition lyophilisee pour la conservation de microbiote dans son ecosysteme |
| CN105504050A (zh) * | 2016-03-03 | 2016-04-20 | 河南欧普生物科技有限公司 | 一种抗安卡拉病毒鸡卵黄抗体的制备方法 |
| US12097226B2 (en) | 2016-04-05 | 2024-09-24 | Nch Corporation | System and method for using a single-serve nutrient spore composition for small scale farm applications |
| MY190858A (en) | 2016-04-05 | 2022-05-12 | Nch Corp | Nutrient rich germinant composition and spore incubation method |
| US10897922B2 (en) | 2016-04-05 | 2021-01-26 | Nch Corporation | Composition and method for germinative compounds in probiotic food and beverage products for human consumption |
| RU2749883C2 (ru) * | 2016-06-14 | 2021-06-18 | Эланко Кэнэда Лимитед | Гранулированный корм для животных, содержащий кормовую добавку, способ его получения и применения |
| CN109475151A (zh) | 2016-06-24 | 2019-03-15 | 叶塞纳吉控股有限公司 | 控制肠道微生物群中有害细菌的免疫调节和促生长组合物及其用途 |
| KR101766430B1 (ko) * | 2016-10-28 | 2017-08-08 | 주식회사 삼양사 | 올리고당을 함유하는 알룰로오스 시럽 및 그 제조방법 |
| CN106819418A (zh) * | 2017-03-27 | 2017-06-13 | 张军军 | 一种超高脂饲料及其制备方法 |
| US10323226B2 (en) | 2017-03-30 | 2019-06-18 | Nch Corporation | Feed material for biomass generator |
| GB201708932D0 (en) * | 2017-06-05 | 2017-07-19 | Probi Ab | Microbial compositions |
| US12377124B2 (en) | 2018-07-04 | 2025-08-05 | Chr. Hansen A/S | Topical compositions comprising viable probiotic bacteria |
| US20210275613A1 (en) * | 2018-07-04 | 2021-09-09 | Chr. Hansen A/S | Aqueous topical compositions comprising viable probiotic bacteria |
| US11401500B2 (en) | 2018-08-29 | 2022-08-02 | Nch Corporation | System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications |
| JP2022505965A (ja) * | 2018-10-26 | 2022-01-14 | ダニスコ・ユーエス・インク | 安定な微生物組成物及び乾燥プロセス |
| KR20210113179A (ko) * | 2018-12-07 | 2021-09-15 | 피벗 바이오, 인크. | 질소 고정 미생물 제품을 위한 안정성이 개선된 중합체 조성물 |
| WO2020130770A1 (es) * | 2018-12-19 | 2020-06-25 | Ajtzakbio S.A.P.I. De C.V. | Composición probiótica de alto valor sin necesidad de cadena de frio, desarrollada para reducir el impacto ambiental, aumentar la producción y mejorar la supervivencia de larvas de camarón |
| JP2022549133A (ja) * | 2019-09-16 | 2022-11-24 | ヴェダンタ バイオサイエンシーズ インコーポレーテッド | 細菌を保存するための方法および組成物 |
| EP4048049A4 (en) * | 2019-10-22 | 2023-12-06 | Massachusetts Institute of Technology | BIOMATERIAL-BASED COMPOSITIONS FOR DELIVERING PLANT GROWTH-PROMOTING MICROBES |
| CN110923145B (zh) * | 2019-12-16 | 2021-07-20 | 天康制药(苏州)有限公司 | 支原体的冻干保护剂与冻干支原体及其制备方法 |
| US11576937B2 (en) | 2020-02-06 | 2023-02-14 | Nch Corporation | Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition |
| US20230080017A1 (en) * | 2020-02-19 | 2023-03-16 | Zantebio Limited | Coated microcapsules and methods for the production thereof |
| RU2746022C1 (ru) * | 2020-04-03 | 2021-04-06 | Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации | Способ стабилизации бактериальных клеток чумного микроба перед сублимационным высушиванием |
| RU2736064C1 (ru) * | 2020-04-03 | 2020-11-11 | Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации | Защитная среда для стабилизации клеток возбудителя туляремии в процессе приготовления и хранения сухих препаратов |
| EP4142477A1 (en) | 2020-05-01 | 2023-03-08 | Pivot Bio, Inc. | Stable liquid formulations for nitrogen-fixing microorganisms |
| JP2022102198A (ja) * | 2020-12-25 | 2022-07-07 | ライオン株式会社 | 内服固形剤 |
| EP4252541A4 (en) * | 2020-12-25 | 2024-11-27 | Nagase Viita Co., Ltd. | METHODS FOR IMPROVING PRODUCTIVITY IN LIVESTOCK AND/OR POULTRY AND METHODS FOR IMPROVING INTESTINAL FLORA IN LIVESTOCK AND/OR POULTRY |
| WO2022171618A1 (en) * | 2021-02-10 | 2022-08-18 | Dsm Ip Assets B.V. | Powderous composition(ii) |
| US20240090558A1 (en) * | 2021-02-10 | 2024-03-21 | Dsm Ip Assets B.V. | Powderous composition (i) |
| CN112843328B (zh) * | 2021-02-25 | 2022-05-13 | 山东大学 | 一种具有抑菌作用的鲍鱼壳粉/ZnO复合材料掺杂的智能水凝胶伤口敷料的制备方法 |
| CN113621519B (zh) * | 2021-08-11 | 2023-07-18 | 河南农业大学 | 一种复合酵母冻干保护剂 |
| CN119255821A (zh) * | 2021-08-25 | 2025-01-03 | 奥古斯汀·T·兹维纳瓦什 | 微生物组递送平台 |
| US20240131108A1 (en) * | 2021-09-29 | 2024-04-25 | Institute of Process Engineering, Chinese Academy of Science | Amino acid-based glass, preparation method and use thereof |
| CN114196579A (zh) * | 2021-12-13 | 2022-03-18 | 张峰 | 一种建筑通风工程用的甲醛微生物净化器 |
| US20250249048A1 (en) * | 2022-04-21 | 2025-08-07 | Limited Liability Company Kinetic-Farm | Intravaginal delivery device for an active ingredient, method of production and use of the device |
| CN116040604B (zh) * | 2022-12-21 | 2025-04-29 | 天津华电南疆热电有限公司 | 一种用于微生物培养的碳源材料及其制备方法 |
| CN116694581A (zh) * | 2023-05-24 | 2023-09-05 | 华南农业大学 | 哈维氏弧菌噬菌体v-ydf132的冻干保护剂及其保藏方法 |
| CN117256857B (zh) * | 2023-07-24 | 2025-12-02 | 浙江大学 | 一种用于制备鱼油微胶囊的复合壁材及其制备方法与应用 |
| WO2025055959A1 (en) * | 2023-09-12 | 2025-03-20 | Bing Biotech Limited | Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith |
| CN117247305A (zh) * | 2023-09-16 | 2023-12-19 | 鲁东大学 | 一种促进植物根系生长的水凝胶及制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6541001B1 (en) * | 1999-08-24 | 2003-04-01 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
| ES2162746B1 (es) * | 1999-10-21 | 2003-02-16 | Lipotec Sa | Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion. |
| DE60121953T2 (de) | 2000-06-27 | 2007-03-08 | F. Hoffmann-La Roche Ag | Herstellungsverfahren von arzneizubereitungen |
| US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
| CA2482448C (en) * | 2002-04-11 | 2014-07-08 | Medimmune Vaccines, Inc. | Preservation of bioactive materials by freeze dried foam |
| WO2004024177A1 (en) * | 2002-09-16 | 2004-03-25 | Quest International Services B.V. | Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein |
| US8871266B2 (en) * | 2003-10-01 | 2014-10-28 | Commonwealth Scientific & Industrial Research Organisation | Probiotic storage and delivery |
| EP1616486A1 (en) * | 2004-07-13 | 2006-01-18 | Friesland Brands B.V. | Powdered compositions containing an edible oil and their use in food products |
| EP1973406B1 (en) * | 2005-12-28 | 2014-03-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form |
| EP2117354B1 (en) * | 2006-12-18 | 2018-08-08 | Advanced BioNutrition Corp. | A dry food product containing live probiotic |
| MY168206A (en) * | 2007-12-20 | 2018-10-15 | Abbott Lab | Stable nutritional powder |
| AU2009306497B2 (en) * | 2008-10-20 | 2015-01-29 | Société des Produits Nestlé S.A. | Nutritional composition with anti-regurgitation properties |
| TWI468157B (zh) * | 2009-04-29 | 2015-01-11 | Intervet Int Bv | 形成錠劑的方法，進行該方法的系統及包含該錠劑的包裝物 |
| US20110070334A1 (en) * | 2009-09-20 | 2011-03-24 | Nagendra Rangavajla | Probiotic Stabilization |
| EP2603100B1 (en) | 2010-08-13 | 2018-04-25 | Advanced BioNutrition Corp. | Dry storage stabilizing composition for biological materials |
-
2013
- 2013-03-22 NZ NZ628912A patent/NZ628912A/en not_active IP Right Cessation
- 2013-03-22 JP JP2015501932A patent/JP6229188B2/ja active Active
- 2013-03-22 AU AU2013234931A patent/AU2013234931B2/en active Active
- 2013-03-22 CA CA2866889A patent/CA2866889C/en active Active
- 2013-03-22 EP EP13764138.7A patent/EP2827905B1/en active Active
- 2013-03-22 KR KR1020147029648A patent/KR102062645B1/ko not_active Expired - Fee Related
- 2013-03-22 WO PCT/US2013/033505 patent/WO2013142792A1/en not_active Ceased
- 2013-03-22 CN CN202210319279.4A patent/CN114601849A/zh active Pending
- 2013-03-22 MY MYPI2014002695A patent/MY178686A/en unknown
- 2013-03-22 SG SG11201405478VA patent/SG11201405478VA/en unknown
- 2013-03-22 BR BR112014023234-2A patent/BR112014023234B1/pt active IP Right Grant
- 2013-03-22 IN IN8599DEN2014 patent/IN2014DN08599A/en unknown
- 2013-03-22 MX MX2014011122A patent/MX356072B/es active IP Right Grant
- 2013-03-22 CN CN201380015928.0A patent/CN104244985A/zh active Pending
- 2013-03-22 ES ES13764138T patent/ES3016483T3/es active Active
- 2013-03-22 RU RU2014136089A patent/RU2666601C2/ru active
- 2013-03-25 AR ARP130100968A patent/AR093204A1/es not_active Application Discontinuation
-
2014
- 2014-09-22 PH PH12014502092A patent/PH12014502092B1/en unknown
- 2014-09-23 CL CL2014002506A patent/CL2014002506A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR093204A1 (es) | 2015-05-27 |
| JP2015517985A (ja) | 2015-06-25 |
| NZ628912A (en) | 2016-06-24 |
| BR112014023234A2 (pt) | 2017-06-20 |
| JP6229188B2 (ja) | 2017-11-15 |
| RU2666601C2 (ru) | 2018-09-11 |
| RU2014136089A (ru) | 2016-05-20 |
| ES3016483T3 (en) | 2025-05-09 |
| MX356072B (es) | 2018-05-14 |
| EP2827905B1 (en) | 2025-03-12 |
| KR20140135845A (ko) | 2014-11-26 |
| CN104244985A (zh) | 2014-12-24 |
| AU2013234931B2 (en) | 2017-12-07 |
| AU2013234931A1 (en) | 2014-09-18 |
| KR102062645B1 (ko) | 2020-01-06 |
| MX2014011122A (es) | 2014-12-05 |
| PH12014502092A1 (en) | 2014-11-24 |
| CN114601849A (zh) | 2022-06-10 |
| EP2827905A4 (en) | 2015-05-06 |
| CA2866889C (en) | 2021-08-31 |
| PH12014502092B1 (en) | 2019-11-20 |
| EP2827905C0 (en) | 2025-03-12 |
| SG11201405478VA (en) | 2014-11-27 |
| IN2014DN08599A (enExample) | 2015-05-22 |
| WO2013142792A1 (en) | 2013-09-26 |
| EP2827905A1 (en) | 2015-01-28 |
| AU2013234931A2 (en) | 2014-12-04 |
| MY178686A (en) | 2020-10-20 |
| BR112014023234B1 (pt) | 2020-12-08 |
| BR112014023234A8 (pt) | 2018-01-16 |
| CA2866889A1 (en) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014002506A1 (es) | Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido. | |
| IL246941B (en) | A pharmaceutical preparation containing erythrocyte thermalizing plp-dependent enzyme and its cofactor | |
| SG11201510671SA (en) | A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions | |
| CL2015000823A1 (es) | Sistema de preparacion de alimentos configurado para producir un producto alimenticio, que comprende una maquina de preparacion de alimentos, y una capsula alimenticia que encierra una cavidad, donde dicha maquina comprende un medio de inyeccion unico y un medio de sellado; metodo; capsula. | |
| BR112015021298A2 (pt) | cápsula de dose individual e processo para a preparação de uma bebida com uma cápsula de dose individual | |
| CL2014002717A1 (es) | Formulación compuesta que comprende una tableta esferoidal de multiunidades (musti) encapsulada en cápsula dura y método para preparar la misma. | |
| ZA201508454B (en) | Method of applying a composition and pharmaceutical composition with a regimen of administering it, including photo-activating the active component | |
| IL243226A0 (en) | History of pyrazole, their preparation and pharmaceutical preparations containing them | |
| EP3058833A4 (en) | Complex carbohydrate formulation for fodder, fodder comprising same, and application | |
| HUE060018T2 (hu) | Ízletességet fokozó anyagok állateledelhez, eljárás elõállításukra és alkalmazásuk | |
| EP3219318A4 (en) | Multi-layered tablet containing drug unstable with respect to light | |
| PL3003379T3 (pl) | Kompozycje farmaceutyczne obejmujące kolagen i hialuronian sodu | |
| MX2017008127A (es) | Producto alimenticio envuelto y procedimiento para la produccion de un producto alimenticio empacado. | |
| EP3018061A4 (en) | Seal head, and container sealed using said seal head | |
| IT1402461B1 (it) | Metodo e macchina per il riempimento di capsule o simili con almeno due prodotti, in particolare prodotti farmaceutici in granuli | |
| EP3012629A4 (en) | Oxygen-detecting multilayered body, and oxygen-detecting packaging material and oxygen-scavenger package using said oxygen-detecting multilayered body | |
| IL246406A0 (en) | History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them | |
| IL243227A0 (en) | History of diaminocyclopentane carboxamide, their preparation and pharmaceutical preparations containing them | |
| IL242438B (en) | Dosage form soft pharmaceutical gelatin capsule | |
| IL243223A0 (en) | History of imidazole, their preparation and pharmaceutical preparations containing them | |
| IL239874B (en) | History of acylguanidine, their preparation and pharmaceutical preparations containing them | |
| IL246297A0 (en) | History of pyrazine, their preparation and pharmaceutical preparations containing them | |
| ES1126055Y (es) | Envase para medicamentos, productos dietéticos y productos similares. | |
| IL239873B (en) | The history of piperidinylcarbazole, their preparation and pharmaceutical preparations containing them | |
| EP3065737A4 (en) | Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form |